Horsemen's representatives told the Ohio Horse Racing Commission March 30 that equine medication rules, which the commission is reviewing, should be breed-specific in nature.
The New York Gaming Commission, during a Jan. 21 public hearing, heard the pros and cons of having different medication rules for Thoroughbred and Standardbred racehorses.
Amid another call for separate medication rules for Thoroughbreds and Standardbreds, the Ohio State Racing Commission has indicated it's not prepared to adopt a uniform national drug policy.
The United States Trotting Association, which in late September dropped out of the Racing Medication and Testing Consortium and rejected model medication rules approved by RCI, has created its own drug advisory committee.
The United States Trotting Association, citing differences in breeds, said Sept. 26 it has ended its membership in the Racing Medication and Testing Consortium and has rejected the proposed national model drug rules.
Most Popular Stories
- Kentucky Derby Winner Monarchos Dies
- Keen Ice Confirmed for Breeders' Cup Classic
- Curlin Colt Sells for $350,000 at F-T October
- Cinco Charlie to Spendthrift Farm
- Arc Winner Found Could Run in BC Classic
- Tapit Colt Late Withdrawal from F-T Sale
- Company Selected to Update AHC Impact Study
- Nine Entries Added to Fasig-Tipton November
- Malibu Moon Filly Sells for $300,000 at F-T
- California Chrome Powerful Late in BC Drill